Rising Drug Prices and Limited Options: The Impact of PBMs on Americans Healthcare

The spotlight remains on pharmacy benefit managers (PBMs) as the nation grapples with their role in rising drug prices. Following several House Oversight Committee hearings addressing PBMs’ contributions to increasing drug costs, and an FTC probe into potential anti-competitive practices within the industry, several states have initiated legal actions against PBMs for price-fixing. Recently, the Arkansas Insurance Department imposed substantial fines on four PBMs for paying pharmacies less than the national average drug acquisition cost—an illegal act under state law.

But how do these legal battles and allegations affect every day Americans, most of whom are unfamiliar with PBMs? The impact is considerable, even if many aren’t aware of it. As previously discussed, PBMs serve as intermediaries that negotiate between pharmacies, insurers, drug manufacturers, and employers or plan sponsors. They also manage formularies, which dictate where medications are listed and the amount insurers pay for each drug, significantly influencing both the accessibility and affordability of treatments for patients. Through strategies like rebates, administrative fees, and formulary management, PBMs have played a key role in driving up healthcare costs and restricting patients’ ability to make choices regarding their own care.

However, this wasn’t always the case. When PBMs first came into existence, they actually benefited American consumers by helping to lower drug prices. They encouraged the use of low-cost generic medications instead of brand-name drugs, assisting the market in shifting towards more affordable, equally effective alternatives.

Despite using this history to defend their current operations and counter legal challenges, PBMs have evolved their business practices in ways that negatively impact consumers and lead to rising prices across the board. The PBM market has grown highly concentrated, with three companies now managing nearly 80% of U.S. prescription claims. This dominance has allowed PBMs to exploit their powerful position in the pharmaceutical supply chain.

Although PBMs often work behind the scenes, their influence on costs and patient choice is undeniable. Unlike hospitals, health insurers, and pharmacies, PBMs are not well-known to most Americans—at least until recently, when their practices became a focal point in national news. Their behind-the-scenes operations contribute to rising costs for consumers and limit the options available to patients.

One significant issue is that PBMs have financial incentives that conflict with the interests of patients and employers. They negotiate with pharmaceutical companies to secure rebates in exchange for placing certain drugs on health plan formularies—the lists of medications covered by insurance. These rebates are often tied to the list prices of drugs: higher prices lead to larger discounts and more substantial rebates. As a result, PBMs favor more expensive drugs with bigger rebates rather than opting for more affordable alternatives. This pricing strategy, based on inflated costs, results in higher out-of-pocket expenses for patients.

Additionally, PBMs restrict patient choice in several ways. By negotiating formularies with drug manufacturers and insurers, they control which medications are available at different price tiers or may exclude certain drugs from coverage altogether. In some cases, this leads to patients being unable to access medications that are the best option for their treatment.

PBMs also influence where patients fill their prescriptions. Often, they steer patients toward pharmacies that are affiliated with their corporate entities, offering lower costs if patients fill prescriptions at these locations. However, this may inconvenience patients or limit their options. In some instances, PBMs may only provide reimbursement for drugs purchased at specific pharmacies within their network, cutting off access to independent or non-affiliated pharmacies.

Another significant concern is the lack of transparency surrounding PBMs. The complexity of their operations often leaves patients, employers, and even regulators in the dark about the true cost of medications. While consumers know what they are paying out-of-pocket, there’s little clarity about how those prices are set or how much of the rebate PBMs keep. This lack of transparency fosters frustration and mistrust. It’s not just the secrecy of PBM practices that is problematic—it’s that this opacity makes it difficult to determine whether their services are justified, given the significant share they take from drug pricing.

While it’s tempting to blame major PBMs for these issues, what’s truly needed is a comprehensive overhaul of the industry. As detailed in my book, Bringing Value to Healthcare, PBMs do not exist in isolation. Although lawsuits are an important tool for curbing the worst of their behaviors, without broad systemic reforms, they may only scratch the surface of the problem without addressing the deeper changes needed in the PBM business model.

PBMs are symptomatic of long-standing problems in the healthcare system: lack of transparency, market consolidation, payment systems that are disconnected from patient outcomes, conflicts of interest, skewed incentives, limited patient autonomy, high costs, and minimal accountability. A more effective model would emphasize transparency in pricing and quality, link payments to meaningful patient outcomes, and ensure accountability across the entire care continuum.

The current investigations and lawsuits are a critical first step, but they should be viewed as part of a broader effort to reform the healthcare system. The national attention being paid to PBMs should serve as a springboard for broader changes across other areas of healthcare. It’s time for patients to have a greater say in the system that so directly impacts their lives.

At MediServ Pharmacy, a local pharmacy in the Bronx, New York, we understand the challenges that patients face in navigating the complex world of prescription medications. Our mission is to provide accessible healthcare solutions while ensuring transparency and support for our community. We are committed to helping you find the best treatment options at affordable prices. For more information about our services and how we can assist you, visit us at mediservpharmacy.com.